LENUREX-K

This brand name is authorized in South Africa.

Active ingredients

The drug LENUREX-K contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Cyclopenthiazide UNII `VX4S2N85F5` - CYCLOPENTHIAZIDE
	Read more about Cyclopenthiazide
`2`	Potassium chloride UNII `660YQ98I10` - POTASSIUM CHLORIDE
	Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.
	Read more about Potassium chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03AB07	Cyclopenthiazide and potassium	C Cardiovascular system → C03 Diuretics → C03A Low-ceiling diuretics, thiazides → C03AB Thiazides and potassium in combination
Discover more medicines within C03AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ZA	Health Products Regulatory Authority	L/18.1/418

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.